Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studies
about
Unveiling changes in the landscape of patient populations in cancer early drug developmentThe Bial 10-2474 Phase 1 Study-A Drug Development Perspective and Recommendations for Future First-in-Human Trials.Risks of phase I research with healthy participants: A systematic reviewMotivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research.Phase 1 healthy volunteer willingness to participate and enrollment preferences.A Systematic Review and Pooled Analysis of Select Safety Parameters Among Normal Healthy Volunteers Taking Placebo in Phase 1 Clinical TrialsThe pharmaceutical industry needs more clinical pharmacologists.An Industry Perspective on the 2017 EMA Guideline on First-in-Human and Early Clinical Trials.A Conceptual Model for the Translation of Bioethics Research and Scholarship.To Report or Not to Report: Exploring Healthy Volunteers' Rationales for Disclosing Adverse Events in Phase I Drug Trials.
P2860
Q28073826-E9726809-ED61-44ED-9566-7B41EACBC4E3Q36339579-9611C00E-308C-44CA-9901-588F5D8572A2Q36665273-7ABB69E5-48A5-4072-BD73-8C06FCE23A66Q38636684-6324FA94-D0E3-437F-A991-220879DA9563Q38647382-348C08B6-E1AD-4025-A019-219B9C7AAB10Q38683174-FDBCCA56-D2B4-40F5-B085-22A9AB278C7FQ48157719-20639115-5D66-4A44-89D1-73D1A3782696Q49503733-F7AB7C1E-CB99-4960-9CBF-043B43CFD844Q51801624-722B8E99-04C7-46ED-8FC7-B277DE703C2BQ52310152-E846364A-AF99-4137-BBA1-00170AF57D67
P2860
Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studies
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Quantifying the risks of non-o ...... ta-analysis of phase I studies
@ast
Quantifying the risks of non-o ...... ta-analysis of phase I studies
@en
Quantifying the risks of non-o ...... ta-analysis of phase I studies
@nl
type
label
Quantifying the risks of non-o ...... ta-analysis of phase I studies
@ast
Quantifying the risks of non-o ...... ta-analysis of phase I studies
@en
Quantifying the risks of non-o ...... ta-analysis of phase I studies
@nl
prefLabel
Quantifying the risks of non-o ...... ta-analysis of phase I studies
@ast
Quantifying the risks of non-o ...... ta-analysis of phase I studies
@en
Quantifying the risks of non-o ...... ta-analysis of phase I studies
@nl
P2093
P2860
P50
P356
P1433
P1476
Quantifying the risks of non-o ...... ta-analysis of phase I studies
@en
P2093
Gabriella Bedarida
Kristy Macci
Nicole B Gabler
P2860
P356
10.1136/BMJ.H3271
P407
P433
P577
2015-06-26T00:00:00Z